FEMY

Femasys Inc. is a biomedical company focused on women's healthcare, developing and commercializing innovative products for reproductive health. The company's lead product, FemBloc, is a permanent birth control solution designed as a non-surgical alternative to tubal ligation. Femasys also developed FemaSeed, an artificial insemination catheter system for infertility treatment. The company's technology platform enables minimally invasive procedures that can be performed in an office setting without general anesthesia. Based in Suwanee, Georgia, Femasys aims to address unmet needs in women's reproductive healthcare with products that offer improved safety, convenience, and patient experience compared to traditional surgical approaches.